Paper8239587
Anti-Mycobacterium avium activity of quinolones: in vitro activities.
Klopman G and 5 others. Antimicrob Agents Chemother, 1993. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Papers, record 8239587. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8239587
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Mycobacterium avium Complex | Major topic |
| Ciprofloxacin | |
| Drug Resistance, Microbial | |
| Humans | |
| Microbial Sensitivity Tests |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SRC AI 30189 | NIAID NIH HHS | United States | U01AI030189 | PubMed and NIH |
Source NIH RePORTER
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,321,736 | Structure-activity relationships among DNA gyrase inhibitors. Synthesis and biological evaluation of 1,2-dihydro-4, 4-dimethyl-1-oxo-2-naphthalenecarboxylic acids as 1-carba bioisosteres of oxolinic acid. | J Med Chem | 1984 | https://conductscience.org/library/papers/6321736 | PubMed |
| 2 | 6,236,748 | In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6236748 | PubMed |
| 3 | 3,005,575 | New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay. | J Med Chem | 1986 | https://conductscience.org/library/papers/3005575 | PubMed |
| 4 | 3,010,848 | Inhibition of Micrococcus luteus DNA gyrase by norfloxacin and 10 other quinolone carboxylic acids. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3010848 | PubMed |
| 5 | 2,940,969 | Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/2940969 | PubMed |
| 6 | 3,015,000 | Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3015000 | PubMed |
| 7 | 3,107,379 | Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. | Am J Med | 1987 | https://conductscience.org/library/papers/3107379 | PubMed |
| 8 | 3,121,243 | In vitro activity of ciprofloxacin and ofloxacin against the Mycobacterium avium-intracellulare complex. | Diagn Microbiol Infect Dis | 1987 | https://conductscience.org/library/papers/3121243 | PubMed |
| 9 | 337,300 | Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/337300 | PubMed |
| 10 | 7,452,690 | Structure-activity relationships of antibacterial 6,7- and 7,8-disubstituted 1-alkyl-1,4-dihydro-4-oxoquinoline-3-carboxylic acids. | J Med Chem | 1980 | https://conductscience.org/library/papers/7452690 | PubMed |
| 11 | 6,786,770 | [A new synthetic antibacterial : 1-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1, 4-dihydroquinolin-3-carboxylic acid (1589 R.B.)]. | C R Seances Acad Sci III | 1981 | https://conductscience.org/library/papers/6786770 | PubMed |
| 12 | 6,271,730 | New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. | J Bacteriol | 1981 | https://conductscience.org/library/papers/6271730 | PubMed |
| 13 | 6,960,805 | In vitro and in vivo activity of DL-8280, a new oxazine derivative. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6960805 | PubMed |
| 14 | 6,222,695 | In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6222695 | PubMed |
| 15 | 3,501,698 | Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3501698 | PubMed |
| 16 | 2,829,716 | Computer automated structure evaluation of quinolone antibacterial agents. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/2829716 | PubMed |
| 17 | 3,138,801 | Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. | Tubercle | 1987 | https://conductscience.org/library/papers/3138801 | PubMed |
| 18 | 2,113,793 | MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2113793 | PubMed |
| 19 | 1,848,296 | Synthesis and biological activity of 5-amino- and 5-hydroxyquinolones, and the overwhelming influence of the remote N1-substituent in determining the structure-activity relationship. | J Med Chem | 1991 | https://conductscience.org/library/papers/1848296 | PubMed |
| 20 | 2,002,456 | Synthesis and biological activity of 5-alkyl-1,7,8-trisubstituted-6-fluoroquinoline-3-carboxylic acids. | J Med Chem | 1991 | https://conductscience.org/library/papers/2002456 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35,990,901 | Neighborhood-based inference and restricted Boltzmann machine for microbe and drug associations prediction. | PeerJ | 2022 | https://conductscience.org/library/papers/35990901 | PubMed |
| 34,443,431 | Efficient Regioselective Synthesis of Novel Condensed Sulfur-Nitrogen Heterocyclic Compounds Based on Annulation Reactions of 2-Quinolinesulfenyl Halides with Alkenes and Cycloalkenes. | Molecules | 2021 | https://conductscience.org/library/papers/34443431 | PubMed |
| 31,413,045 | Transferable Mechanisms of Quinolone Resistance from 1998 Onward. | Clin Microbiol Rev | 2019 | https://conductscience.org/library/papers/31413045 | PubMed |
| 21,372,133 | Bacterial conversion of folinic acid is required for antifolate resistance. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21372133 | PubMed |
| 10,991,858 | Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10991858 | PubMed |
| 10,898,685 | Antimycobacterial activities of novel levofloxacin analogues. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10898685 | PubMed |
| 8,913,479 | N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913479 | PubMed |
| 8,913,475 | Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8913475 | PubMed |
| 8,891,145 | Structure-activity relationships of quinolone agents against mycobacteria: effect of structural modifications at the 8 position. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8891145 | PubMed |
| 8,727,932 | New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. | J Clin Microbiol | 1996 | https://conductscience.org/library/papers/8727932 | PubMed |
| 8,549,419 | Activity of quinolones against mycobacteria. | Drugs | 1995 | https://conductscience.org/library/papers/8549419 | PubMed |
| 8,239,588 | Anti-Mycobacterium avium activity of quinolones: structure-activity relationship studies. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8239588 | PubMed |
| 7,986,010 | In vitro anti-Mycobacterium avium activities of quinolones: predicted active structures and mechanistic considerations. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7986010 | PubMed |
| 7,872,747 | A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/7872747 | PubMed |
| 7,793,885 | Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7793885 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8239587
GET https://conductscience.org/api/papers/v1/8239587/references?page=2